Sheri Hammock
Acute Care · Burlington, NCNPI 1619417789
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $570, 6.4 times the $89 reported in 2021.
Across 84 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Esperion Therapeutics, Inc.$194
- Novartis$190
- Heartflow, Inc.$154
- Pfizer$125
- Amgen$118
- Johnson & Johnson$113
- plus $774 from 16 others
What the payments were for
- Food & beverage$1,65499%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Esperion Therapeutics, Inc. | 6 | $194 |
| Novartis | 9 | $190 |
| Heartflow, Inc. | 5 | $154 |
| Pfizer | 7 | $125 |
| Amgen | 7 | $118 |
| Johnson & Johnson | 7 | $113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $110 |
| AstraZeneca | 6 | $98 |
| Merck | 4 | $75 |
| Irhythm Technologies, Inc. | 3 | $69 |
| Novo Nordisk | 4 | $67 |
| Alnylam Pharmaceuticals Inc. | 3 | $57 |
| Boehringer Ingelheim | 3 | $48 |
| Scpharmaceuticals Inc. | 2 | $44 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Flowphysix Inc | 2 | $34 |
| Bayer | 1 | $29 |
| Abiomed | 1 | $29 |
| Agepha Pharma FZ LLC | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Bardy Diagnostics, Inc. | 1 | $20 |
| Altathera Pharmaceuticals LLC | 1 | $14 |
How this compares
$1,668 in reported general payments places this provider in the 85th percentile of 312 acute care providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 90 | $73,294 |
| XareltoRivaroxaban | 34 | $21,965 |
| EntrestoSacubitril/Valsartan | 19 | $20,497 |
| Repatha SureclickEvolocumab | 26 | $14,580 |
| BrilintaTicagrelor | 15 | $8,342 |
| Atorvastatin Calcium | 64 | $1,060 |
| Metoprolol Succinate | 74 | $875 |
| ClopidogrelClopidogrel Bisulfate | 54 | $797 |
| Rosuvastatin Calcium | 61 | $754 |
| Amlodipine Besylate | 94 | $688 |
| Losartan Potassium | 56 | $683 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 55 | $605 |
| Potassium Chloride | 26 | $526 |
| Bisoprolol Fumarate | 13 | $478 |
| Pantoprazole Sodium | 12 | $452 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $125 | $73,29490 claims |
| Johnson & JohnsonXarelto | $113 | $21,96534 claims |
| NovartisEntresto | $190 | $20,49719 claims |
| AstraZenecaBrilinta | $98 | $8,34215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 312 acute care providers in North Carolina.
Other acute care in Burlington
- Jordan LeeBurlington$2K
- Benjamin HocuttGreenville$25K
- Matthew KuhnPinehurst$16K
- Robin TruppApex$14K
- Suzanne HartmannRaleigh$12K
- Leigh CasperSalisbury$12K
- Juliana QuagraineCharlotte$11K
- Sarah GroceGreensboro$10K
- Lauren CowellNew Bern$10K
- Erica TaylorPinehurst$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.